CN Patent

CN117209500B — Shp2抑制剂、其晶型及其制备方法与用途

Assigned to Shanghai Lingji Biotechnology Co ltd · Expires 2026-04-10 · 0y expired

What this patent protects

本发明公开了SHP2抑制剂、其晶型及其制备方法与用途。本发明公开了式(I)所示化合物B晶型、式(II)所示化合物和其A晶型、式(III)所示化合物和其A晶型、式(IV)所示化合物和其A晶型、式(V)所示化合物和其A晶型和式(VI)所示化合物和其A晶型及其制备方法和用途。本发明公开的化合物及其晶型具有以下一个或多个优点：性质稳定、引湿性好、生物利用度好、具有良好的成药前景。

USPTO Abstract

本发明公开了SHP2抑制剂、其晶型及其制备方法与用途。本发明公开了式(I)所示化合物B晶型、式(II)所示化合物和其A晶型、式(III)所示化合物和其A晶型、式(IV)所示化合物和其A晶型、式(V)所示化合物和其A晶型和式(VI)所示化合物和其A晶型及其制备方法和用途。本发明公开的化合物及其晶型具有以下一个或多个优点：性质稳定、引湿性好、生物利用度好、具有良好的成药前景。

Drugs covered by this patent

Patent Metadata

Patent number: CN117209500B
Jurisdiction: CN
Classification: —
Expires: 2026-04-10
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Lingji Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.